pergolide has been researched along with Idiopathic Parkinson Disease in 280 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 72 (25.71) | 18.7374 |
| 1990's | 52 (18.57) | 18.2507 |
| 2000's | 137 (48.93) | 29.6817 |
| 2010's | 18 (6.43) | 24.3611 |
| 2020's | 1 (0.36) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Chen, X; Wen, S; Zhang, Q; Zhou, C | 1 |
| Haga, R; Kon, T; Tomiyama, M; Ueno, T | 1 |
| Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ | 1 |
| Ciobica, A; Hritcu, L | 1 |
| El Moutaouakil, B; El Otmani, H; Rafai, MA; Raji, L; Slassi, I | 1 |
| Dong, J; Liu, J; Su, Y; Sun, S; Wang, L; Yan, P | 1 |
| Andreatta, W; Shah, P | 1 |
| Ikeda, S; Ishizaki, T; Nakaoka, S; Nakayama, T; Satoh, T; Urushihara, H; Yamamoto, M | 1 |
| Bianchini, E; Bramanti, P; Cilia, R; Ciurleo, R; de Luise, C; Di Lorenzo, G; Ilardi, M; Italiano, D; Pezzoli, G; Polimeni, G; Rijnbeek, P; Ross, D; Stocchi, F; Sturkenboom, M; Trifirò, G; Vacca, L; Zanettini, R | 1 |
| Kaneko, Y; Kogure, T; Okamoto, K; Tatsumi, T | 1 |
| Andrejak, M; Dupuy, D; Gérard, P; Godefroy, O; Lesbre, JP | 1 |
| Duong-Hua, M; Lang, A; Marras, C; Rochon, P; Sykora, K; Zadikoff, C | 1 |
| Cosyns, B; Droogmans, S; Van Camp, G | 1 |
| Bares, M; Krajcovicová, L; Rektor, I; Rektorová, I | 1 |
| Aydemir, T; Bader, H; Cetin, S; Kizkin, S; Meral, H; Ozben, B; Ozben, S; Ozer, F; Ozturk, O; Tiras, R | 1 |
| Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C | 1 |
| Asai, H; Furiya, Y; Hirano, M; Kanbayashi, T; Morikawa, M; Shimizu, T; Udaka, F; Ueno, S | 1 |
| Sherlock, M; Steeds, R; Toogood, AA | 1 |
| Barreiro, B; González, C; Salvadó, M | 1 |
| Nijssen, PC; Weber, WE | 1 |
| Berendse, H; Bloem, BR; Boon, AJ; de Koning-Tijssen, MA; Hovestadt, A; Nijssen, PC; van Hilten, JJ; van Laar, T; Weber, WE | 1 |
| Fujioka, S; Iwamoto, K; Kawamura, M; Nakajima, M; Ohno, H | 1 |
| Cannas, A; Floris, G; Marrosu, F; Marrosu, MG; Piga, M; Serra, A; Solla, P; Tacconi, P | 1 |
| Pullan, PT | 1 |
| Caltagirone, C; Carlesimo, GA; Costa, A; Dell'Agnello, G; Peppe, A | 1 |
| Bloom, CI; Wilson, GE | 1 |
| Hirai, K; Ono, S; Tokuda, E | 1 |
| Apostolakis, EE; Baikoussis, NG; Fokaeas, E; Karanikolas, M; Koniari, I; Prokakis, C; Tselikos, D | 1 |
| Kataoka, H; Ueno, S | 1 |
| Antonini, A; Gatto, G; Gentile, R; Pezzoli, G; Tesei, S; Zanettini, R | 2 |
| Arai, M | 1 |
| Kubota, K; Ooba, N; Yamaguchi, T | 1 |
| Ikeda, S; Ishizaki, T; Morikawa, K; Nakaoka, S; Nakayama, T; Satoh, T; Urushihara, H | 1 |
| Adam, JJ; Duits, A; Scholtissen, B; van Houdt, H; Visser-Vandewalle, V; Winogrodzka, A | 1 |
| Damier, P; Derkinderen, P; Giumelli, B; Meyniel, C | 1 |
| Biedermann, T; Chou, MT; Djapri, C; Hadi, R; Huang, B; Jang, J; Krantz, DE; Lam, HA; Lawal, HO; Lawless, GM; Maidment, NT; Roberts, L; Shahi, V; Terrell, A | 1 |
| Dorsher, PT; Edwards, WD; Freeman, WD; Safford, RE; Van Gerpen, J | 1 |
| Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H | 1 |
| Aziz, I; Greenstone, MA; Kastelik, JA; Morice, AH; Thompson, R | 1 |
| Gekht, AB | 1 |
| Bain, PG; Navan, P | 1 |
| Kuhlmann, A; Müller, T; Reimer, J | 1 |
| Clarke, CE; Guttman, M | 1 |
| Bonnet, AM; Houeto, JL | 1 |
| Bain, PG; Findley, LJ; Jeffs, JA; Navan, P; Pearce, RK | 2 |
| Bergmans, P; Booij, J; Stoof, JC; van Royen, EA; Winogrodzka, A; Wolters, EC | 1 |
| MacMahon, DG | 1 |
| Bares, M; Dostál, V; Ehler, E; Fanfrdlová, Z; Fiedler, J; Klajblová, H; Kulist'ák, P; Rektor, I; Rektorová, I; Ressner, P; Svátová, J; Urbánek, K; Velísková, J | 1 |
| Driver-Dunckley, E; Samanta, J; Stacy, M | 1 |
| Cosyns, B; Flamez, A; Goldstein, J; Perdaens, C; Schoors, D; Van Camp, G | 1 |
| de la Llave, Y; Garcia de Yébenes, J; Garcia-Borreguero, D; Larrosa, O; Schwarz, C | 1 |
| Lang, AE; Razmy, A; Shapiro, CM | 1 |
| Chigir', IP; Fedorova, NV; Krivonos, OV | 1 |
| Araki, I; Kuno, S; Mizuta, E; Yamasaki, S | 1 |
| Cosyns, B; De Sutter, J; Decoodt, P; Flamez, A; Moerman, C; Muyldermans, L; Santens, P; Schoors, D; Van Camp, G; Van Zandijcke, M; Weytjens, C | 1 |
| Hotta, M; Kamo, T; Kawakami, M; Nemoto, S; Oshima, J; Shimojo, S; Shiraishi, M; Sugihara, H; Takahashi, Y; Yasaki, S | 1 |
| Blin, O | 1 |
| Bonuccelli, U | 1 |
| Hattori, N | 1 |
| Grosset, DG; Grosset, KA | 1 |
| Burkhard, PR; Flachsbart, KD; Fross, RD; Horvath, J; Kleiner-Fisman, G; Lang, AE; Lerch, R; Liaudat, S; Pache, JC; Rakowski, H; Raskoff, WJ; Stalder, H | 1 |
| Agarwal, P; Fahn, S; Frucht, SJ | 1 |
| Jennette, JC; Mauro, M; Moll, S; Wang, TH | 1 |
| Bares, M; Kanovský, P; Pohanka, M; Pulkrábek, J; Rektor, I | 2 |
| Baseman, DG; Baseman, JG; Dewey, RB; Laskar, SR; O'Suilleabhain, PE; Reimold, SC | 1 |
| Brusa, L; Koch, G; Peppe, A; Pierantozzi, M; Ruggieri, S; Stanzione, P; Tiraboschi, P | 1 |
| Grosset, D; Grosset, K; Macphee, G; Needleman, F | 1 |
| Clarke, CE; Deane, KH; Spieker, S | 1 |
| Horowski, R; Jähnichen, S; Pertz, HH | 1 |
| Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P | 1 |
| Bagheri, H; Montastruc, JL; Pathak, A; Rascol, O | 1 |
| Ludin, HP | 2 |
| Grosset, D; Grosset, K; Lees, A | 1 |
| Bain, PG; Findley, LJ; Navan, P; Pearce, RK; Undy, MB | 1 |
| Beger, T; Bilici, A; Cetinkaya, S; Doventas, A; Erdincler, DS; Karadag, B; Ogut, G; Tezcan, V | 1 |
| Gerlach, M; Reichmann, H; Riederer, P | 1 |
| Boggie, DT; Chan, H; Delattre, ML; Morreale, AP; Plowman, BK; Schaefer, MG | 1 |
| Roth, J; Růzicka, E; Ulmanová, O | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
| Comella, CL; Janko, K; Morrissey, M | 1 |
| Bax, JJ; Jukema, JW; van Hilten, JJ; van Strater, AC | 1 |
| Neshige, R | 1 |
| Kishore, A; Lang, AE | 1 |
| Hundemer, HP; Oehlwein, C; Polzer, U; Schwarz, J; Storch, A; Trenkwalder, C; Winkelmann, J | 1 |
| Gauthier, P; Jankovic, J; Manian, P; Tintner, R | 1 |
| Heckman, MG; Kaplan, J; Waller, EA | 1 |
| Arnold, G; Bergamasco, B; Dujardin, M; Frewer, P; Gimenez-Roldan, S; Grosset, DG; Hundemer, HP; Leenders, KL; Lledó, A; Oertel, WH; Sampaio, C; Schwarz, J; Wolters, E; Wood, A | 1 |
| Isonishi, K; Kaneko, S; Kashiwaba, T; Kitaguchi, M; Mikami, T; Moriwaka, F; Muraki, M; Onozuka, H; Sugawara, T; Tsutsui, H; Yamada, S | 1 |
| Cannas, A; Floris, G; Solla, P; Tacconi, P | 1 |
| Chung, EJ; Kim, JY; Lee, WY; Yoon, WT | 1 |
| Morgan, JC; Sethi, KD; Sharma, P | 1 |
| Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G | 1 |
| Lang, A; Rochon, P; Zadikoff, C | 1 |
| Johnston, W; Martin, WR; Puttagunta, L; Scozzafava, J; Takahashi, J | 1 |
| Chan, PL; Holford, NH; Kieburtz, K; Nutt, JG; Shoulson, I | 1 |
| Chung, EJ; Kim, JY; Lee, WY; Park, SW | 1 |
| Duda, JE; Goveas, J; Moberg, PJ; Morales, KH; Potenza, MN; Siderowf, AD; Stern, MB; Weintraub, D | 1 |
| Morgan, JC; Sethi, KD | 1 |
| Cannas, A; Floris, G; Loi, D; Marcia, E; Marrosu, MG; Solla, P; Tacconi, P | 1 |
| Bernardi, S; Meco, G | 1 |
| Larner, AJ | 1 |
| Fuhrmann, JT; Junghanns, S; Koch, R; Oelwein, C; Reichmann, H; Simonis, G; Storch, A; Strasser, RH | 1 |
| Andersohn, F; Garbe, E; Haverkamp, W; Schade, R; Suissa, S | 1 |
| Foncke, EM; Goudriaan, AE; Schmand, B; Schuurman, PR; Smeding, HM; Speelman, JD | 1 |
| Akoglu, A; Akyol, A; Sevincok, L | 1 |
| Erginöz, E; Kenangil, G; Koldas, L; Ozekmekçi, S; Sahin, T | 1 |
| Dewey, RB; O'Suilleabhain, PE; Reimold, SC | 1 |
| Linkova, H; Penicka, M; Ruzicka, E | 1 |
| Barget, M; Debilly, B; Derost, PP; Durif, F; Lemaire, JJ; Llorca, PM; Morand, D; Ouchchane, L; Ulla, M | 1 |
| Imamura, A; Obata, T; Tanaka, M; Tsuboi, Y; Yamada, T | 1 |
| Senol, MG; Togrol, RE | 1 |
| Ahmed, MR; Bychkov, E; Dalby, KN; Gurevich, EV | 1 |
| Fuhrmann, JT; Simonis, G; Strasser, RH | 1 |
| Antonini, A; Poewe, W | 1 |
| Línková, H; Nováková, L; Penicka, M; Roth, J; Růzicka, E; Ulmanová, O | 1 |
| Berti, C; Bianchi, MC; Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G; Tosetti, M | 1 |
| Boon, P; De Bodt, M; De Letter, M; Estercam, I; Santens, P; Van Borsel, J; Van Maele, G | 1 |
| Funakoshi, T; Iwata, S; Wakamatsu, M; Yoshimoto, M | 1 |
| Agid, Y; Anzouan-Kacou, JB; Bonnet, AM; Corvol, JC; Fauveau, E; Girault, C; Isnard, R; Lacomblez, L; Lebrun-Vignes, B; Lechat, P | 1 |
| Bejjani, BP; Jabre, MG | 1 |
| Arcoraci, V; Morgante, L; Savica, R; Tari, M; Trifirò, G | 1 |
| Chihara, N; Hayakawa, M; Nakase, H; Shiio, Y; Yoshimura, M | 1 |
| Bharucha, KJ; Blevins, SM | 1 |
| Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K | 1 |
| Burton, K; Calne, DB | 1 |
| Lees, AJ; Stern, GM | 1 |
| Duvoisin, RC; Heikkila, RE; Manzino, L | 1 |
| Bystritsky, A; Engel, J; Goldstein, M; Lieberman, A; Mino, S; Regev, I | 1 |
| Beckman, J; Burton, K; Calne, DB; Martin, WR | 1 |
| Jankovic, J | 3 |
| Glatt, S; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Calne, DB; Dambrosia, JM; Foster, N; Larsen, TA; LeWitt, PA; Newman, RP; Raphaelson, MI; Ward, CD | 1 |
| Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L | 1 |
| De Bruyne, H; Jeanty, P; Lowenthal, A; Van den Kerchove, M | 1 |
| Cote, L; Fahn, S; Ilson, J; Mayeux, R; Stern, Y | 1 |
| Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Nelson, J; Neophytides, A; Walker, R | 2 |
| Login, IS | 1 |
| Agid, Y; Barroche, G; de Smet, Y; Lhermitte, F; Mear, JY; Weber, M | 1 |
| Fahn, S; Jackson-Lewis, V; Reches, A; Wagner, HR; Yablonskaya-Alter, E | 1 |
| Glantz, R; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Diamond, SG; Markham, CH | 2 |
| Côté, L; Fahn, S; Ilson, J | 1 |
| Goldstein, M; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A | 2 |
| Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Thompson, C | 1 |
| Askenasy, JJ; Yahr, MD | 2 |
| Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N | 1 |
| Greising, J; Kleinberg, DL; Kupersmith, M; Lieberman, A; Neophytides, A; Todd, J | 1 |
| Ford, J; Jackson, JA; Jankovic, J | 1 |
| Brincat, S; Lang, AE; Marsden, CD; Parkes, D; Quinn, NP; Sheehy, MP | 1 |
| Cote, LJ; Fahn, S; Ilson, J; Mayeux, R; Snider, SR | 1 |
| Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R | 1 |
| Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Toone, B | 1 |
| Glantz, RH; Glatt, SL; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Klawans, HL; Tanner, CM | 1 |
| Goldstein, M; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R | 1 |
| Goldstein, M; Kleinberg, D; Kupersmith, M; Leibowitz, M; Lieberman, A; Neophytides, A; Pact, V | 1 |
| González, ER | 1 |
| Eadie, MJ | 1 |
| Kondo, T; Mizuno, Y; Narabayashi, H | 1 |
| Angeleri, V; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G | 1 |
| Mark, MH; Sage, JI | 1 |
| Gsell, W; Lange, KW; Naumann, M; Oestreicher, E; Rausch, WD; Riederer, P | 1 |
| Angeleri, VA; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G | 1 |
| Fahn, S; Grimes, JD; Hurtig, H; Jankovic, J; Klawans, H; Kurlan, R; Muenter, M; Olanow, CW; Shoulson, I; Stern, M | 1 |
| Comella, CL; Ristanovic, RK; Tanner, CM | 1 |
| Clow, A; Glover, V; Sandler, M | 1 |
| Agid, Y; Bonnet, AM; Dubois, B; Marconi, R; Serre, I | 1 |
| Angulo Cuesta, J; Guil Cid, M; Jiménez, FJ; López Alvarez, YJ; Sánchez-Chapado, M | 1 |
| Shan, DE; Yeh, SI | 1 |
| Gutiérrez, F; Jiménez-Jiménez, FJ; López-Alvarez, J; Miquel, J; Montero, E; Sánchez-Chapado, M; Sierra, A | 1 |
| Ahlskog, JE | 1 |
| Devahasatin, V; Poungvarin, N; Prayoonwiwat, N; Viriyavejakul, A | 1 |
| Facca, A; Sanchez-Ramos, J | 1 |
| Kuno, S | 1 |
| Scheidtmann, K; Schwarz, J; Trenkwalder, C | 1 |
| Cabrera-Valdivia, F; Fernández-Lliria, A; Gasalla, T; Jiménez-Jiménez, FJ; Ortí-Pareja, M; Tallón-Barranco, A | 1 |
| Graham, JM; Grünewald, RA; Sagar, HJ | 1 |
| Hayabara, T; Kanzaki, N; Sato, K | 1 |
| de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R | 1 |
| Durso, R; Fernandez, HH | 1 |
| Amano, K; Takakura, K | 1 |
| Dick, DJ; Pilling, JB; Shaunak, S; Wilkins, A | 1 |
| Factor, SA | 1 |
| Kellett, MW; Steiger, MJ | 1 |
| Barone, P; Bermejo-Pareja, F; Bravi, D; Kulisevsky, J; Malagù, S; Marconi, R; Rost, N; Weiser, R | 1 |
| Weiner, WJ | 1 |
| Montastruc, JL; Rascol, O; Senard, JM | 1 |
| Chuda, M; Hayabara, T; Ihara, Y; Kuroda, S | 1 |
| Ahlskog, JE; Burnett, OL; Maraganore, DM; Matsumoto, JY; O'Connor, MK; Stark, KF; Turk, MF; Uitti, RJ | 1 |
| Antonini, A; Barichella, M; Canesi, M; Mariani, CB; Pezzoli, G; Tesei, S; Zecchinelli, AL | 1 |
| Lund, BC; Neiman, RF; Perry, PJ | 1 |
| van der Worp, B | 1 |
| Schapira, AH | 1 |
| Ferreira, JJ; Galitzky, M; Montastruc, JL; Rascol, O | 1 |
| Clarke C, E; Speller J, M | 2 |
| Bisulli, A; Nassetti, SA; Santangelo, M; Strafella, AP; Tassinari, CA; Tropeani, A; Valzania, F | 1 |
| Barbanoj, M; Berthier, ML; Estévez-González, A; García-Sánchez, C; Gironell, A; Kulisevsky, J; Pascual-Sedano, B | 1 |
| Kesler, S; Niehaus, DJ; Seedat, S; Stein, DJ | 1 |
| Blasucci, L; Goetz, CG; Kujawa, K; Leurgans, S; Raman, R | 1 |
| Gershman, M; Hamaoui, E; Varsano, S | 1 |
| Crevits, L; De Ridder, K; Hanse, M; Versijpt, J | 1 |
| Sternon, J; Supiot, F; Zegers de Beyl, D | 1 |
| Cantarero, S; Fanjul, S; García Ruiz, PJ; Hernández, J | 1 |
| Hanna, PA; Jankovic, J; Ondo, WG; Ratkos, L | 1 |
| Masson, C | 1 |
| Jankovic, J; Le, WD | 1 |
| Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A | 1 |
| Fukui, T; Hira, K; Shimbo, T; Takemura, M | 1 |
| Doder, M; Hely, M; Koller, W; Lees, A | 1 |
| Hillman, R; Parvez, F; Pendleton, RG; Sayed, M | 1 |
| Balachandran, KP; Berg, GA; Oldroyd, KG; Stewart, D | 1 |
| Bartalini, S; Battistini, N; Giannini, F; Lombardi, C; Lugaresi, E; Passero, S; Rocchi, R; Rossi, S; Ulivelli, M | 1 |
| De Mari, M; Lamberti, P; Zenzola, A | 1 |
| Bares, M; Kanovský, P; Pohanka, M; Rektor, I | 1 |
| Yokochi, F | 1 |
| Diamond, BI; Klawans, HL; Koller, WC; Nausieda, PA; Weiner, WJ | 1 |
| Koller, WC | 1 |
| Berg, MJ; Collier, DS; Fincham, RW | 1 |
| Diederich, NJ; Goetz, CG | 1 |
| Apathy, JM; Bowsher, RR; Carlson, KH; Compton, JA; DeSante, KA; Wolen, RL | 1 |
| Clemens, JA; Date, I; Felten, DL; Felten, SY; Steece-Collier, K | 1 |
| Ahlskog, JE; Bailey, PA; Muenter, MD; Stevens, PM | 1 |
| Ahlskog, JE; Carmichael, SW; Kelly, PJ; Nelson, A; Okazaki, H; Richelson, E; Stoddard, SL; Tyce, GM; van Heerden, JA | 1 |
| Mariani, C; Pezzoli, G; Reganati, P; Scarlato, G; Zecchinelli, A | 1 |
| Jacobs, MB; Varon, J | 1 |
| Ogawa, N | 1 |
| Goetz, CG | 1 |
| Robin, DW | 1 |
| Sage, JI; Zimmerman, T | 1 |
| Clissold, SP; Langtry, HD | 1 |
| Rinne, UK | 2 |
| Carroll, VS; Goetz, CG; Klawans, HL; Shannon, KM; Tanner, CM | 1 |
| Baumann, G; Chin, L; Lieberman, A | 1 |
| Boyce, S; Jenner, P; Marsden, CD | 1 |
| Goldstein, M; Leibowitz, M; Lieberman, AN | 1 |
| Ahlskog, JE; Muenter, MD | 2 |
| Delwaide, PJ; Gonce, M | 1 |
| Lieberman, AN | 1 |
| McHale, DM; Sage, JI | 1 |
| Factor, SA; Sanchez-Ramos, JR; Weiner, WJ | 1 |
| Alberts, MJ; Olanow, CW | 2 |
| Knapp, R; Kurlan, R; Miller, C; Murphy, G; Shoulson, I | 1 |
| Jankovic, J; Orman, J | 1 |
| Lees, AJ; Stern, GM; Wright, A | 1 |
| Duvoisin, RC; Sage, JI | 2 |
| Klawans, HL; Paleologos, N | 1 |
| Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 2 |
| Diamond, SG; Markham, CH; Treciokas, LJ | 1 |
| Hamill, R; Kurlan, R; Levy, R; Macik, B; Miller, C; Shoulson, I | 1 |
| Chhablani, R; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Goldstein, M; Lieberman, AN | 1 |
| Gopinathan, G; Lieberman, AN; Neophytides, A | 1 |
| Agid, Y; Dubois, B | 1 |
| Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Nelson, J; Walker, R | 1 |
| Jiang, DH | 1 |
43 review(s) available for pergolide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pergolide; Pramipexole | 2023 |
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline | 2013 |
Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis.
Topics: Antidepressive Agents, Tricyclic; Benzothiazoles; Depression; Humans; Odds Ratio; Parkinson Disease; Pergolide; Pramipexole; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2013 |
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone | 2002 |
DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
Topics: Bromocriptine; Dopamine Agonists; Ergot Alkaloids; Humans; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic | 2002 |
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
Dopamine agonist monotherapy in Parkinson's disease.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
The pharmacokinetics of pergolide in Parkinson's disease.
Topics: Animals; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Genetic Variation; Humans; Metabolic Clearance Rate; Parkinson Disease; Pergolide; Receptors, Dopamine | 2003 |
Comparing dopamine agonists in Parkinson's disease.
Topics: Antiparkinson Agents; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Sleep Wake Disorders | 2003 |
Appropriate dosing of pergolide in monotherapy and adjunctive therapy in Parkinson's disease.
Topics: Antiparkinson Agents; Asian People; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Parkinson Disease; Pergolide; White People | 2003 |
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Humans; Levodopa; Nitrophenols; Parkinson Disease; Pergolide; Tolcapone | 2004 |
[Are there innovations in the treatment of Parkinson's disease?].
Topics: Antiparkinson Agents; Cannabis; Cholinesterase Inhibitors; Controlled Clinical Trials as Topic; Dopamine Agonists; Heart Valve Diseases; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Pergolide; Phenylcarbamates; Placebos; Rivastigmine; Time Factors | 2004 |
Retroperitoneal fibrosis caused by pergolide in a patient with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Female; Humans; Magnetic Resonance Imaging; Parkinson Disease; Pergolide; Retroperitoneal Fibrosis | 2004 |
Sleep attacks in patients receiving dopamine-receptor agonists.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Pramipexole; Restless Legs Syndrome; Thiazoles | 2005 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Cardiac valvulopathy associated with pergolide use.
Topics: Antiparkinson Agents; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2006 |
Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists.
Topics: Antiparkinson Agents; Cabergoline; Cross-Sectional Studies; Dopamine Agonists; Drug Combinations; Echocardiography; Ergolines; Ergot Alkaloids; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide; Product Surveillance, Postmarketing | 2007 |
Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease.
Topics: Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2007 |
Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.
Topics: Antiparkinson Agents; Aortic Valve Insufficiency; Dose-Response Relationship, Drug; Echocardiography; Female; Heart Valve Diseases; Humans; Logistic Models; Male; Middle Aged; Mitral Valve Insufficiency; Odds Ratio; Parkinson Disease; Pergolide; Prospective Studies; Risk Factors; Tricuspid Valve Insufficiency | 2007 |
The pharmacology of Parkinson's disease: basic aspects and recent advances.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine | 1984 |
Neuroprotection by dopamine agonists.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Bromocriptine; Dopamine Agonists; Humans; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Pergolide | 1994 |
Effects of dopaminergic drugs on superoxide dismutase: implications for senescence.
Topics: Aging; Animals; Corpus Striatum; Enzyme Induction; Free Radicals; Humans; Isatin; Life Expectancy; Nerve Degeneration; Parkinson Disease; Pergolide; Rats; Selegiline; Substantia Nigra; Superoxide Dismutase | 1993 |
[Retroperitoneal fibrosis secondary to treatment with L-dopa analogues for Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Retroperitoneal Fibrosis | 1995 |
Treatment of early Parkinson's disease: are complicated strategies justified?
Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Selegiline | 1996 |
[Treatment of Parkinson's disease with multiple drugs].
Topics: Amantadine; Bromocriptine; Cholinergic Antagonists; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide | 1997 |
Dopamine agonists.
Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome | 1999 |
The initial treatment of Parkinson's disease should begin with levodopa.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors | 1999 |
Treatment of Parkinson's disease should begin with a dopamine agonist.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles | 1999 |
Pergolide for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide | 2000 |
Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide | 2000 |
Are dopamine receptor agonists neuroprotective in Parkinson's disease?
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles | 2001 |
Chronic pericardial constriction linked to the antiparkinsonian dopamine agonist pergolide.
Topics: Aged; Antiparkinson Agents; Humans; Male; Parkinson Disease; Pergolide; Pericardiectomy; Pericarditis, Constrictive; Recurrence | 2002 |
Initiating treatment of Parkinson's disease.
Topics: Amantadine; Antioxidants; Dopamine Agents; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide | 1992 |
Parkinsonism treatment: Part III--Update.
Topics: Antioxidants; Dopamine Agents; Female; Fetal Tissue Transplantation; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline; Vitamin E | 1992 |
Dopaminergic agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine | 1992 |
Age-related decline in the dopaminergic nigrostriatal system: the oxidative hypothesis and protective strategies.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Corpus Striatum; Dopamine; Humans; Neurons; Oxidation-Reduction; Parkinson Disease; Pergolide; Substantia Nigra | 1992 |
[New anti-parkinsonian drugs].
Topics: Antiparkinson Agents; Bromocriptine; Humans; Lisuride; Parkinson Disease; Pergolide; Picolinic Acids; Selegiline | 1991 |
Dopaminergic agonists in the treatment of Parkinson's disease.
Topics: Bromocriptine; Dopamine Agents; Humans; Parkinson Disease; Pergolide | 1990 |
Pergolide in the treatment of Parkinson's disease.
Topics: Humans; Parkinson Disease; Pergolide | 1991 |
Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease.
Topics: Animals; Humans; Parkinson Disease; Pergolide | 1990 |
Receptor changes during chronic dopaminergic stimulation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome | 1988 |
Long-term use of dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors | 1985 |
Bromocriptine in Parkinson disease.
Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1985 |
54 trial(s) available for pergolide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both.
Topics: Adult; Aged; Analysis of Variance; Case-Control Studies; Dopamine Agonists; Drug Therapy, Combination; Echocardiography; Female; Heart Valve Diseases; Humans; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Single-Blind Method; Young Adult | 2009 |
Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Humans; Japan; Outcome Assessment, Health Care; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
Topics: Attention; Benzothiazoles; Cognition; Dopamine Agonists; Female; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pergolide; Pramipexole; Reaction Time; Severity of Illness Index; Task Performance and Analysis | 2009 |
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2013 |
[Pergolide: a useful agonist for the treatment of Parkinson disease].
Topics: Antiparkinson Agents; Disease Progression; Dopamine Agonists; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 2002 |
Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Surveys and Questionnaires; Thiazoles; Tremor | 2003 |
Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.
Topics: Activities of Daily Living; Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Depression; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Pergolide; Placebos; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Single-Blind Method; Thiazoles; Treatment Outcome | 2003 |
L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.
Topics: Aged; Antiparkinson Agents; Disorders of Excessive Somnolence; Double-Blind Method; Female; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Reaction Time; Selegiline | 2003 |
Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor.
Topics: Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Thiazoles; Tremor | 2003 |
[A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease].
Topics: Activities of Daily Living; Benzophenones; Benzothiazoles; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitriles; Nitrophenols; Parkinson Disease; Pergolide; Pramipexole; Quality of Life; Thiazoles; Tolcapone; Treatment Outcome | 2004 |
Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cabergoline; Ergolines; Humans; Parkinson Disease; Pergolide; Prospective Studies; Treatment Outcome | 2004 |
Pergolide mesylate can improve sexual dysfunction in patients with Parkinson's disease: the results of an open, prospective, 6-month follow-up.
Topics: Aged; Antiparkinson Agents; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Prospective Studies; Sexual Dysfunction, Physiological; Treatment Outcome | 2004 |
Pergolide effect on cognitive functions in early-mild Parkinson's disease.
Topics: Aged; Cognition; Cross-Over Studies; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 2005 |
Trial of subtherapeutic pergolide in de novo Parkinson's disease.
Topics: Adult; Aged; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Prospective Studies | 2005 |
A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Thiazoles; Tremor | 2005 |
Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.
Topics: Age Factors; Aged; Antiparkinson Agents; Brain; Circadian Rhythm; Constipation; Dizziness; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Placebos; Sex Factors; Sleep; Sleep Wake Disorders; Treatment Outcome | 2005 |
The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial.
Topics: Aged; Antiparkinson Agents; Erectile Dysfunction; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Prolactin; Prospective Studies; Sexual Dysfunction, Physiological | 2005 |
Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study.
Topics: Adult; Age of Onset; Aged; Brain; Dopamine Agonists; Double-Blind Method; Dyskinesias; Early Diagnosis; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Prospective Studies; Radionuclide Imaging; Surveys and Questionnaires | 2006 |
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Hypertrophy, Left Ventricular; Indoles; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Tricuspid Valve Insufficiency | 2007 |
Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide.
Topics: Aged; Dopamine Agonists; Dose-Response Relationship, Drug; Echocardiography; Female; Heart Valve Diseases; Humans; Incidence; Male; Middle Aged; Mitral Valve; Parkinson Disease; Pergolide | 2007 |
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study.
Topics: Adult; Aged; Aspartic Acid; Choline; Creatinine; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Parkinson Disease; Pergolide; Protons; Treatment Outcome | 2007 |
Pergolide and lisuride for levodopa-induced oscillations.
Topics: Clinical Trials as Topic; Ergolines; Female; Humans; Lisuride; Male; Parkinson Disease; Pergolide | 1981 |
Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy.
Topics: Adult; Aged; Antiparkinson Agents; Bulbar Palsy, Progressive; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Placebos | 1983 |
A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease.
Topics: Clinical Trials as Topic; Disability Evaluation; Ergolines; Female; Humans; Levodopa; Male; Parkinson Disease; Pergolide; Sleep; Time Factors | 1983 |
Comparison of pergolide and bromocriptine therapy in parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
Pergolide in late-stage Parkinson disease.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders | 1982 |
Pergolide in the treatment of Parkinson's disease.
Topics: Double-Blind Method; Humans; Parkinson Disease; Pergolide; Time Factors | 1995 |
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1995 |
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide; Single-Blind Method; Treatment Outcome | 1994 |
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.
Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Motor Skills; Neurologic Examination; Parkinson Disease; Pergolide | 1994 |
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1995 |
Experience of pergolide in the treatment of Chinese parkinsonian patients with dose-related fluctuations.
Topics: Aged; Antiparkinson Agents; Delayed-Action Preparations; Humans; Middle Aged; Parkinson Disease; Pergolide | 1995 |
An open label trial of pergolide in Thai patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Thailand; Treatment Outcome | 1996 |
Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist?
Topics: Aged; Aged, 80 and over; Bromocriptine; Carbidopa; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Stereotaxic Techniques; Treatment Outcome | 1997 |
Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group.
Topics: Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1999 |
The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
Topics: Aged; Brain; Brain Mapping; Carbidopa; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Motor Skills; Nerve Tissue Proteins; Parkinson Disease; Pergolide; Putamen; Tomography, Emission-Computed, Single-Photon | 1999 |
Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study.
Topics: Aged; Analysis of Variance; Drug Administration Schedule; Drug Therapy, Combination; Electric Stimulation; Humans; Levodopa; Middle Aged; Motor Cortex; Neural Inhibition; Parkinson Disease; Pergolide; Reaction Time; Sensory Thresholds; Severity of Illness Index; Transcranial Magnetic Stimulation | 2000 |
Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Dopamine Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neuropsychological Tests; Parkinson Disease; Pergolide | 2000 |
Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson's patients.
Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Female; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Psychiatric Status Rating Scales; Saccades | 2000 |
Switching from pergolide to pramipexole in patients with Parkinson's disease.
Topics: Accidental Falls; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Edema; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Pramipexole; Prospective Studies; Receptors, Dopamine; Sweating; Thiazoles; Treatment Outcome | 2001 |
Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations.
Topics: Antiparkinson Agents; Benzophenones; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nitrophenols; Parkinson Disease; Pergolide; Quality of Life; Tolcapone; Treatment Outcome | 2001 |
[Pergolide mesylate in the treatment of Parkinson's disease resistant to other treatments. First Italian experience].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1991 |
Pergolide and selegiline for Parkinson's disease.
Topics: Animals; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Levodopa; Nerve Degeneration; Parkinson Disease; Pergolide; Phenethylamines; Selegiline | 1989 |
Treatment of Parkinson's disease with pergolide: a double-blind study.
Topics: Activities of Daily Living; Adult; Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Random Allocation | 1988 |
Pergolide: long-term use in Parkinson's disease.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Placebos; Retrospective Studies | 1988 |
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 1988 |
Double-blind controlled study of pergolide mesylate in the treatment of Parkinson's disease.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Prospective Studies; Random Allocation | 1987 |
Double-blind assessment of potential pergolide-induced cardiotoxicity.
Topics: Aged; Bradycardia; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Ergolines; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Prospective Studies | 1986 |
Parallel double-blind study of pergolide in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Motor Skills; Parkinson Disease; Pergolide; Random Allocation | 1987 |
Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Random Allocation | 1987 |
Double-blind trial of pergolide for Parkinson's disease.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Ergolines; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1985 |
Long-term experience with pergolide therapy of advanced parkinsonism.
Topics: Aged; Ambulatory Care; Antiparkinson Agents; Clinical Trials as Topic; Drug Administration Schedule; Ergolines; Female; Hospitalization; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Shy-Drager Syndrome; Time Factors | 1985 |
Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease.
Topics: Aged; Clinical Trials as Topic; Electrocardiography; Ergolines; Female; Heart; Heart Diseases; Humans; Male; Middle Aged; Myocardial Contraction; Parkinson Disease; Pergolide | 1985 |
Pergolide therapy in Parkinson's disease: a double-blind, placebo-controlled study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Ergolines; Gait; Humans; Levodopa; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Pergolide; Random Allocation | 1985 |
183 other study(ies) available for pergolide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study.
Topics: Adenosine A2 Receptor Antagonists; Age Factors; Aged; Antiparkinson Agents; Calcium Channel Blockers; Case-Control Studies; Catechols; Cohort Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Impulsive Behavior; Japan; Longitudinal Studies; Male; Nitriles; Parkinson Disease; Pergolide; Purines; Retrospective Studies; Surveys and Questionnaires; Zonisamide | 2018 |
Intranigral lipopolysaccharide administration induced behavioral deficits and oxidative stress damage in laboratory rats: relevance for Parkinson's disease.
Topics: Animals; Behavior, Animal; Glutathione Peroxidase; Hippocampus; Lipid Peroxidation; Lipopolysaccharides; Male; Malondialdehyde; Maze Learning; Memory; Microinjections; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Pergolide; Rats; Rats, Wistar; Rotation; Substantia Nigra; Superoxide Dismutase; Temporal Lobe | 2013 |
[Severe punding in Parkinson's disease].
Topics: Consanguinity; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Substitution; Female; Humans; Indoles; Parkinson Disease; Pergolide; Stereotyped Behavior; Young Adult | 2015 |
Reversible Hypotony and Choroidal Effusion Following the Use of Pergolide for Parkinson's Disease.
Topics: Aged; Choroid Diseases; Dopamine Agonists; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypotension; Parkinson Disease; Pergolide; Ultrasonography | 2015 |
Prescribing pattern of anti-Parkinson drugs in Japan: a trend analysis from 2005 to 2010.
Topics: Aged; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Drug Prescriptions; Ergolines; Female; Humans; Japan; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 2014 |
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in Italy.
Topics: Aged; Antiparkinson Agents; Cabergoline; Cohort Studies; Echocardiography; Ergolines; Female; Guideline Adherence; Heart Valve Diseases; Heart Valves; Humans; Incidence; Italy; Male; Middle Aged; Parkinson Disease; Pergolide; Practice Guidelines as Topic; Prevalence; Retrospective Studies; Risk Factors; Supranuclear Palsy, Progressive | 2015 |
Rheumatoid arthritis accompanied by Parkinson disease.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Dopamine Agonists; Female; Humans; Middle Aged; Parkinson Disease; Pergolide | 2008 |
Valvular heart disease in patients with Parkinson's disease treated with pergolide. Course following treatment modifications.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Confidence Intervals; Dopamine Agonists; Electrocardiography; Female; Follow-Up Studies; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Odds Ratio; Parkinson Disease; Pergolide; Retrospective Studies | 2008 |
Pergolide associated cardiac valvulopathy based on Ontario administrative data.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Databases, Factual; Dopamine Agonists; Female; Health Services Administration; Heart Failure; Heart Valve Diseases; Humans; Levodopa; Male; Ontario; Parkinson Disease; Pergolide | 2008 |
Pergolide and valvular heart disease: the lower the better?
Topics: Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide; Practice Guidelines as Topic; Restless Legs Syndrome; Ultrasonography | 2008 |
Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Echocardiography; Female; Heart Valve Diseases; Heart Valves; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole | 2008 |
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease.
Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors | 2009 |
Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease.
Topics: Adult; Aged; Dopamine Agonists; Female; Humans; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; Neuropeptides; Orexins; Parkinson Disease; Pergolide; Radioimmunoassay; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Severity of Illness Index; Sleep Wake Disorders | 2009 |
Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do.
Topics: Cabergoline; Dopamine Agonists; Echocardiography; Ergolines; Heart Valve Diseases; Heart Valves; Humans; Hyperprolactinemia; Parkinson Disease; Pergolide; Tricuspid Valve Insufficiency | 2009 |
[Pleural effusion caused by pergolide].
Topics: Aged; Dopamine Agonists; Humans; Male; Parkinson Disease; Pergolide; Pleural Effusion | 2009 |
[Impulse control disorder induced by the use of dopamine agonists].
Topics: Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Restless Legs Syndrome; Risk Factors | 2009 |
[Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide].
Topics: Dopamine Agonists; Echocardiography; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide; Risk Factors | 2009 |
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy.
Topics: Aged; Aged, 80 and over; Benserazide; Benzothiazoles; Brain; Carbidopa; Dopamine Agents; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Tomography, Emission-Computed, Single-Photon; Tropanes | 2009 |
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Male; Parkinson Disease; Pergolide; Prolactin; Serotonin 5-HT2 Receptor Agonists; Ultrasonography | 2009 |
Rounded atelectasis and respiratory compromise secondary to pergolide use.
Topics: Aged; Antiparkinson Agents; Humans; Male; Parkinson Disease; Pergolide; Pleural Diseases; Pulmonary Atelectasis | 2009 |
Effects of pergolide mesilate on metallothionein mRNAs expression in a mouse model for Parkinson disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Brain; Disease Models, Animal; Dopamine Agonists; Gene Expression; Lipid Peroxidation; Malondialdehyde; Metallothionein; Mice; Mice, Inbred C57BL; Parkinson Disease; Pergolide; RNA, Messenger | 2009 |
Cardiac surgery in a patient with retroperitoneal fibrosis and heart valvulopathy, both due to pergolide medication for Parkinson's disease.
Topics: Aged; Aortic Valve Insufficiency; Dopamine Agonists; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Retroperitoneal Fibrosis; Treatment Outcome | 2009 |
Compulsive singing associated with a dopamine agonist in Parkinson disease.
Topics: Aged, 80 and over; Compulsive Behavior; Dopamine Agonists; Female; Humans; Parkinson Disease; Pergolide | 2010 |
Regression of cardiac valvulopathy related to ergot-derived dopamine agonists.
Topics: Adult; Aged; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Heart Valve Diseases; Humans; Italy; Male; Middle Aged; Parkinson Disease; Patient Selection; Pergolide; Prevalence; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Ultrasonography | 2011 |
The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems. Are there any new Parkinson's drugs which are safer for patients with heart risks?
Topics: Antiparkinson Agents; Aortic Valve Insufficiency; Cabergoline; Dopamine Agonists; Ergolines; Health Knowledge, Attitudes, Practice; Humans; Parkinson Disease; Pergolide | 2009 |
Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson's disease patients.
Topics: Aged; Arginine Vasopressin; Benzothiazoles; Carbidopa; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole | 2011 |
The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008.
Topics: Cabergoline; Databases, Factual; Dopamine Agonists; Drug Prescriptions; Drug Utilization Review; Ergolines; Government Regulation; Heart Valve Diseases; Humans; Insurance Claim Review; Japan; Legislation, Drug; Parkinson Disease; Pergolide; Regression Analysis; Ultrasonography | 2011 |
Echocardiography for the detection of valvulopathy associated with the use of ergot-derived dopamine agonists in patients with Parkinson's disease.
Topics: Adult; Aged; Cabergoline; Dopamine Agonists; Drug Labeling; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Incidence; Japan; Male; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies; Risk Factors | 2011 |
Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance.
Topics: Aged; Benserazide; Benzothiazoles; Carbidopa; Cues; Deep Brain Stimulation; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Psychomotor Performance; Reaction Time; Subthalamic Nucleus | 2011 |
Continuous buccolingual masticatory dyskinesia in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Mastication; Movement Disorders; Parkinson Disease; Pergolide | 2012 |
Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depression.
Topics: Animals; Animals, Genetically Modified; Antiparkinson Agents; Dacarbazine; Drosophila melanogaster; Drosophila Proteins; Drug Evaluation, Preclinical; Female; Fertility; Larva; Locomotion; Male; Mutation; Parkinson Disease; Pergolide; Synapses; Vesicular Monoamine Transport Proteins | 2014 |
Combined pergolide-associated valvular heart disease and achilles tendon contractures.
Topics: Achilles Tendon; Aged; Contracture; Dopamine Agonists; Female; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2012 |
Pergolide-induced lung disease in patients with Parkinson's disease.
Topics: Cough; Dopamine Agonists; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pergolide; Pneumonia; Pulmonary Fibrosis; Tomography, X-Ray Computed | 2002 |
Long term tolerability of high dose ergoline derived dopamine agonist therapy for the treatment of Parkinson's disease.
Topics: Adult; Aged; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Drug Tolerance; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Time | 2002 |
Neuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolide.
Topics: Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Pergolide | 2002 |
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Caudate Nucleus; Cocaine; Corpus Striatum; Disease Progression; Female; Humans; Male; Nerve Degeneration; Parkinson Disease; Pergolide; Pramipexole; Putamen; Radiopharmaceuticals; Receptors, Dopamine D2; Reproducibility of Results; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2003 |
The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa.
Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Thiazoles | 2003 |
Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Female; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Recurrence; Retrospective Studies; Suicide; Thiazoles | 2003 |
Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Aortic Valve Insufficiency; Echocardiography; Fatal Outcome; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Tricuspid Valve Insufficiency | 2003 |
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
Topics: Aged; Benzothiazoles; Bromocriptine; Disorders of Excessive Somnolence; Dopamine Agonists; Dose-Response Relationship, Drug; Ergot Alkaloids; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Polysomnography; Pramipexole; Prospective Studies; Sleep; Thiazoles; Wakefulness | 2004 |
Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients.
Topics: Aged; Bromocriptine; Female; Humans; Middle Aged; Parkinson Disease; Patient Selection; Pergolide; Urination Disorders | 2004 |
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease.
Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 2004 |
Pergolide in Parkinson's disease: time for a change?
Topics: Antiparkinson Agents; Dopamine Agonists; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2004 |
Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.
Topics: Adult; Aged; Cabergoline; Carbidopa; Dopamine Agonists; Drug Combinations; Echocardiography, Transesophageal; Ergolines; Ergot Alkaloids; Female; Heart Valve Diseases; Humans; Levodopa; Male; Parkinson Disease; Pergolide | 2004 |
Diagnosis and management of pergolide-induced fibrosis.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Biopsy, Needle; Bronchi; Female; Fibrosis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Pergolide; Pleural Diseases; Retroperitoneal Fibrosis; Tomography, X-Ray Computed | 2004 |
Extensive fibromuscular dysplasia in a patient with Parkinson disease.
Topics: Female; Fibromuscular Dysplasia; Humans; Middle Aged; Parkinson Disease; Pergolide | 2004 |
Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.
Topics: Aged; Antiparkinson Agents; Aortic Valve Insufficiency; Cardiomyopathy, Restrictive; Cohort Studies; Disease Progression; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pericarditis; Pulmonary Valve Insufficiency; Single-Blind Method; Tricuspid Valve Insufficiency; Ultrasonography | 2004 |
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles | 2004 |
Fibrotic valvular heart disease is not related to chemical class but to biological function: 5-HT2B receptor activation plays crucial role.
Topics: Dopamine Agents; Fibroblasts; Fibrosis; Heart Valve Diseases; Humans; Myoblasts; Parkinson Disease; Pergolide; Receptors, Serotonin | 2004 |
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2004 |
Dopaminagonists and fibrotic valvular heart disease: further considerations.
Topics: Dopamine Agonists; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2004 |
[Special issue: the reports presented during the 5th Parkinson's Physicians' Symposium].
Topics: Antiparkinson Agents; Dopamine Agonists; Globus Pallidus; Humans; Parkinson Disease; Pergolide; Stereotaxic Techniques; Subthalamic Nucleus | 2004 |
Levodopa in the treatment of Parkinson's disease: current controversies.
Topics: Animals; Antiparkinson Agents; Apomorphine; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haplorhini; Levodopa; Lisuride; Parkinson Disease; Pergolide | 2005 |
[Organ changes induced by ergot derivative dopamine agonist drugs: time to change treatment guidelines in Parkinson's disease?].
Topics: Aged; Dopamine Agonists; Female; Fibrosis; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 2005 |
[Severe insuffiency of the aortic and tricuspidal valves associated with pergolide use].
Topics: Antiparkinson Agents; Aortic Valve Insufficiency; Dopamine Agonists; Female; Heart Valve Prosthesis Implantation; Humans; Middle Aged; Parkinson Disease; Pergolide; Tricuspid Valve Insufficiency | 2005 |
[Optimum dosage of pergolide in patients with Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Quality of Life; Surveys and Questionnaires | 2005 |
Normalization of voice in spasmodic dysphonia during transient global amnesia.
Topics: Aged; Amnesia, Transient Global; Antiparkinson Agents; Female; Humans; Levodopa; Parkinson Disease; Pergolide; Speech Therapy; Voice Disorders; Voice Training | 2005 |
High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Dyskinesias; Endpoint Determination; Female; Germany; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pergolide; Psychotic Disorders; Retrospective Studies | 2005 |
Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Humans; Lung; Male; Molecular Structure; Parkinson Disease; Pergolide; Pleura; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Thiazoles; Tomography, X-Ray Computed | 2005 |
Valvular heart disease in patients taking pergolide.
Topics: Adult; Aged; Aged, 80 and over; Aortic Valve Insufficiency; Case-Control Studies; Dopamine Agonists; Echocardiography; Female; Humans; Male; Medical Records Systems, Computerized; Middle Aged; Parkinson Disease; Pergolide; Severity of Illness Index | 2005 |
[Effects of low-dose pergolide therapy on cardiac valves in patients with Parkinson's disease].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Dose-Response Relationship, Drug; Echocardiography, Doppler; Female; Heart Valves; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 2005 |
Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation.
Topics: Antiparkinson Agents; Benserazide; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Homeostasis; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Paraphilic Disorders; Parkinson Disease; Pedophilia; Pergolide | 2006 |
Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide.
Topics: Antiparkinson Agents; Dose-Response Relationship, Drug; Echocardiography; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 2006 |
Hiccups associated with dopamine agonists in Parkinson disease.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Hiccup; Humans; Male; Parkinson Disease; Pergolide; Pramipexole; Thiazoles | 2006 |
Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System; Bromocriptine; Disability Evaluation; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Pergolide; Prognosis; Survival Analysis | 2006 |
Valvular heart disease in pergolide-treated Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Female; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2006 |
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.
Topics: Algorithms; Antiparkinson Agents; Bayes Theorem; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Models, Biological; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Selegiline; Treatment Outcome | 2006 |
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Dopamine Agonists; Echocardiography; Ergot Alkaloids; Heart Valve Diseases; Humans; Middle Aged; Parkinson Disease; Pergolide; Reference Values | 2006 |
Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Follow-Up Studies; Gambling; Humans; Indoles; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Thiazoles | 2006 |
Pergolide-induced ergotism.
Topics: Aged; Antiparkinson Agents; Ergotism; Female; Humans; Parkinson Disease; Pergolide | 2006 |
Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia.
Topics: Age of Onset; Antiparkinson Agents; Cognition; Humans; Iatrogenic Disease; Male; Middle Aged; Motor Activity; Paraphilic Disorders; Parkinson Disease; Pergolide | 2006 |
Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Clomipramine; Clozapine; Delusions; Depressive Disorder; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders | 2007 |
Medical hazards of the internet: gambling in Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Gambling; Humans; Internet; Levodopa; Male; Parkinson Disease; Pergolide | 2006 |
Dopamine agonists and the risk of cardiac-valve regurgitation.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cabergoline; Case-Control Studies; Cohort Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists | 2007 |
Valvular heart disease and the use of dopamine agonists for Parkinson's disease.
Topics: Aged; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Parkinson Disease; Pergolide; Regression Analysis; Risk; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Ultrasonography | 2007 |
Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease.
Topics: Antiparkinson Agents; Cognition Disorders; Deep Brain Stimulation; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Subthalamic Nucleus; Time Factors | 2007 |
Quetiapine in a case with Parkinson disease and pathological gambling.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiazepines; Gambling; Humans; Male; Parkinson Disease; Pergolide; Quetiapine Fumarate | 2007 |
Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline.
Topics: Aged; Antiparkinson Agents; Aortic Valve Insufficiency; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies; Tricuspid Valve Insufficiency | 2007 |
Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Case-Control Studies; Echocardiography; Female; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole | 2007 |
Dopamine agonists and valvular heart disease.
Topics: Dopamine Agonists; Dose-Response Relationship, Drug; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 2007 |
Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
Topics: Activities of Daily Living; Age Factors; Aged; Antiparkinson Agents; Bipolar Disorder; Catechols; Cognition; Combined Modality Therapy; Communication; Deep Brain Stimulation; Dysarthria; Electrodes, Implanted; Emotions; Female; Humans; Levodopa; Male; Middle Aged; Movement; Neuropsychological Tests; Nitriles; Parkinson Disease; Pergolide; Prejudice; Quality of Life; Severity of Illness Index; Subthalamic Nucleus; Treatment Outcome; Weight Gain | 2007 |
[Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
Topics: Dopamine Agonists; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Restless Legs Syndrome | 2007 |
Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study.
Topics: Antiparkinson Agents; Benzothiazoles; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Male; Parkinson Disease; Patient Selection; Pergolide; Pramipexole; Research Design; Sex Factors | 2007 |
Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Levodopa; Mitogen-Activated Protein Kinase 1; Opioid Peptides; Oxidopamine; Parkinson Disease; Pergolide; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Signal Transduction; Up-Regulation | 2007 |
Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Drug Therapy, Combination; Dysarthria; Female; Humans; Levodopa; Linguistics; Male; Middle Aged; Parkinson Disease; Pergolide; Sound Spectrography; Speech Acoustics; Speech Intelligibility; Speech Production Measurement; Verbal Behavior | 2007 |
Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Exploratory Behavior; Humans; Levodopa; Male; Mice; Mice, Transgenic; Motor Activity; Parkinson Disease; Peptide Fragments; Pergolide; Receptors, Dopamine D2 | 2008 |
The variability of levodopa response in Parkinson's disease: is sensitization reversible?
Topics: Antiparkinson Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease; Pergolide; Treatment Outcome | 2008 |
Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agent.
Topics: Aged; Antiparkinson Agents; Cabergoline; Cardiovascular Diseases; Dopamine Agonists; Ergolines; Female; Humans; Male; Parkinson Disease; Pergolide; Treatment Outcome | 2008 |
[Low dose pergolide induced systemic edema and pleural effusion in a patient with Parkinson's disease].
Topics: Aged; Edema; Female; Fibrosis; Heart Valves; Humans; Parkinson Disease; Pergolide; Peritoneum; Pleura; Pleural Effusion; Severity of Illness Index | 2008 |
Sclerosing mesenteritis: an ergot-related complication of pergolide therapy in Parkinson's disease?
Topics: Adult; Dopamine Antagonists; Ergot Alkaloids; Humans; Male; Panniculitis, Peritoneal; Parkinson Disease; Pergolide; Tremor | 2008 |
The frequency of cardiac valvular regurgitation in Parkinson's disease.
Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence | 2008 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
Topics: Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Ergolines; Female; Hydroxydopamines; Oxidopamine; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains | 1982 |
Therapeutic potentials of centrally acting dopamine and alpha 2-adrenoreceptor agonists.
Topics: Adrenergic alpha-Agonists; Animals; Dopamine; Ergolines; Haplorhini; Humans; Neurons; Norepinephrine; Parkinson Disease; Pergolide; Quinpirole; Rats | 1983 |
Dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1984 |
Pergolide therapy in Parkinson's disease.
Topics: Aged; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1984 |
Pergolide therapy for Parkinson's disease: neurobehavioral changes.
Topics: Adult; Aged; Behavior; Ergolines; Female; Humans; Male; Middle Aged; Nervous System; Parkinson Disease; Pergolide; Psychological Tests | 1984 |
Long-term treatment with pergolide: decreased efficacy with time.
Topics: Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1984 |
Pergolide versus bromocriptine.
Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pergolide | 1984 |
Pergolide in the treatment of Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1984 |
Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum.
Topics: Animals; Corpus Striatum; Denervation; Ergolines; Levodopa; Male; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1984 |
Pergolide in Parkinson's disease.
Topics: Aged; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
Evaluating the evaluations: or how to weigh the scales of parkinsonian disability.
Topics: Drug Evaluation; Ergolines; Humans; Parkinson Disease; Pergolide | 1983 |
Painful dystonic spasms in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Ergolines; Female; Humans; Hypotension; Male; Middle Aged; Nausea; Pain; Parkinson Disease; Pergolide; Spasm | 1984 |
Pergolide and lisuride in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Ergolines; Humans; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies | 1984 |
Pergolide in the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Domperidone; Ergolines; Humans; Levodopa; Mental Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Pergolide | 1984 |
One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease.
Topics: Athetosis; Carbidopa; Chorea; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Hypotension; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1984 |
Suppression of REM rebound by Pergolide.
Topics: Aged; Antiparkinson Agents; Electroencephalography; Ergolines; Humans; Male; Parkinson Disease; Pergolide; Sleep Deprivation; Sleep, REM | 1984 |
Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's disease.
Topics: Animals; Circadian Rhythm; Ergolines; Female; Haplorhini; Humans; Macaca mulatta; Parkinson Disease; Pergolide; Prolactin | 1980 |
Progressive supranuclear palsy: clinical features and response to treatment in 16 patients.
Topics: Aged; Bromocriptine; Bulbar Palsy, Progressive; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
Lisuride and pergolide in Parkinson's disease.
Topics: Aged; Disability Evaluation; Dose-Response Relationship, Drug; Ergolines; Humans; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Sleep | 1983 |
The effects of pergolide on the cardiovascular system of 40 patients with Parkinson's disease.
Topics: Adult; Aged; Cardiovascular System; Ergolines; Female; Heart Diseases; Heart Ventricles; Humans; Hypotension, Orthostatic; Male; Middle Aged; Myocardial Contraction; Parkinson Disease; Pergolide; Pulse; Sick Sinus Syndrome | 1983 |
Pergolide treatment in parkinsonism.
Topics: Adult; Aged; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Respiration Disorders | 1983 |
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Disability Evaluation; Drug Evaluation; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1983 |
Dopa dose-dependent sexual deviation.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Humans; Male; Middle Aged; Paraphilic Disorders; Parkinson Disease; Pergolide | 1983 |
Pergolide mesylate and idiopathic Parkinson disease.
Topics: Adolescent; Adult; Carbidopa; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Parkinson Disease; Pergolide | 1982 |
Further studies with pergolide in Parkinson disease.
Topics: Adult; Aged; Carbidopa; Confusion; Drug Combinations; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1982 |
Pergolide mesylate: new therapy for Parkinson disease.
Topics: Antiparkinson Agents; Arrhythmias, Cardiac; Ergolines; Humans; Levodopa; Parkinson Disease; Pergolide | 1982 |
The use of pergolide, a potent dopamine agonist, in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Random Allocation; Time Factors | 1982 |
Treatment of advanced Parkinson disease with pergolide.
Topics: Aged; Arrhythmias, Cardiac; Brain; Dopamine; Double-Blind Method; Ergolines; Humans; Levodopa; Middle Aged; Neurons; Parkinson Disease; Pergolide; Random Allocation | 1981 |
Parkinson's disease: new drugs help but no cure on the horizon.
Topics: Antiparkinson Agents; Ergolines; Humans; Lisuride; Parkinson Disease; Pergolide | 1981 |
Treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Pergolide; Prognosis; Selegiline | 1995 |
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.
Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating | 1995 |
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.
Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM | 1993 |
Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide.
Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Female; Humans; Parkinson Disease; Pergolide; Retroperitoneal Fibrosis | 1995 |
High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide | 1996 |
Improvement of motor fluctuations in patients with Parkinson's disease following treatment with high doses of pergolide and cessation of levodopa.
Topics: Aged; Amantadine; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Pergolide | 1997 |
Cenesthetic hallucinations in a patient with Parkinson's disease.
Topics: Aged; Clozapine; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide | 1997 |
Hallucinosis in idiopathic Parkinson's disease.
Topics: Aged; Bromocriptine; Cognition Disorders; Depressive Disorder; Dopamine Agonists; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Psychomotor Disorders; Retrospective Studies; Severity of Illness Index; Time Factors | 1997 |
Improved cardiac iodine-123 metaiodobenzylguanidine accumulation after drug therapy in a patient with Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Coronary Circulation; Droxidopa; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Heart; Heart Diseases; Humans; Iodine Radioisotopes; Parkinson Disease; Pergolide; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1997 |
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor | 1997 |
[Dopamine agonists in the management of Parkinson disease. D1- and D2-receptors regulate the motor function].
Topics: Antiparkinson Agents; Dopamine Agonists; Humans; Motor Activity; Parkinson Disease; Pergolide | 1994 |
[New trends in the treatment of Parkinson disease: current findings on neuroprotection and high dose dopamine agonist therapy].
Topics: Antiparkinson Agents; Humans; Parkinson Disease; Pergolide | 1997 |
Clozapine for dopaminergic-induced paraphilias in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Carbidopa; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Paraphilic Disorders; Parkinson Disease; Pergolide | 1998 |
Pericardial, retroperitoneal, and pleural fibrosis induced by pergolide.
Topics: Aged; Antiparkinson Agents; Fibrosis; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pericardium; Pleura; Retroperitoneal Fibrosis | 1999 |
Deterioration in parkinsonism with low-dose pergolide.
Topics: Adult; Aged; Antiparkinson Agents; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Parkinson Disease; Pergolide; Receptors, Dopamine | 1999 |
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data.
Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Erythrocytes; Humans; Hydroxyl Radical; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pergolide; Severity of Illness Index; Statistics as Topic; Superoxide Dismutase; Time Factors | 1999 |
An overnight switch to ropinirole therapy in patients with Parkinson's disease. Short communication.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Bromocriptine; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Therapeutic Equivalency | 1999 |
Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosis.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Indoles; Parkinson Disease; Pergolide; Retroperitoneal Fibrosis | 1999 |
Pergolide monotherapy for Parkinson's disease.
Topics: Dopamine Agonists; Double-Blind Method; Humans; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic | 1999 |
Sleep attacks (sleep episodes) with pergolide.
Topics: Antiparkinson Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide | 2000 |
Sleep attacks and Parkinson's disease treatment.
Topics: Accidents, Traffic; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Piribedil | 2000 |
Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents.
Topics: Antipsychotic Agents; Carbidopa; Dopamine Agonists; Drug Therapy, Combination; Female; Gambling; Humans; Impulsive Behavior; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Risperidone; Treatment Outcome | 2000 |
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Female; Humans; Hypotension, Orthostatic; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Thiazoles | 2000 |
Pergolide-induced dyspnea, bilateral pleural effusion and peripheral edema.
Topics: Aged; Dopamine Agonists; Dyspnea; Echocardiography, Doppler; Edema; Humans; Male; Parkinson Disease; Pergolide; Pleural Effusion | 2000 |
[Dopaminergic agonists in the treatment of Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles | 2000 |
[Sleep attacks and pergolide mesylate].
Topics: Aged; Antiparkinson Agents; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Male; Parkinson Disease; Pergolide | 2001 |
[Parkinson's disease].
Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Catechols; Depressive Disorder; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Follow-Up Studies; Humans; Indoles; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors | 2001 |
Pergolide and Parkinson's disease: new preparation. No clear benefit.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Treatment Outcome | 2000 |
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2001 |
Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan.
Topics: Aged; Bromocriptine; Cost-Benefit Analysis; Dopamine Agonists; Female; Hospitalization; Humans; Japan; Male; Markov Chains; Middle Aged; Parkinson Disease; Pergolide; Quality-Adjusted Life Years | 2001 |
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Bromocriptine; Disease Models, Animal; Drosophila melanogaster; Genotype; Levodopa; Motor Activity; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pergolide; Postural Balance; Synapses; Synucleins | 2002 |
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD.
Topics: Adult; Disorders of Excessive Somnolence; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Electroencephalography; Female; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep, REM; Wakefulness | 2002 |
Antiparkinsonian treatment in pregnancy.
Topics: Adult; Antiparkinson Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Levodopa; Neurologic Examination; Parkinson Disease; Pergolide; Pregnancy; Pregnancy Complications | 2002 |
Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson's disease.
Topics: Antiparkinson Agents; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Parkinson Disease; Penile Erection; Pergolide; Sexual Behavior; Sexual Dysfunctions, Psychological | 2002 |
[Multiple system atrophy which had been treated as juvenile Parkinson's disease].
Topics: Adult; Antiparkinson Agents; Humans; Levodopa; Male; Multiple System Atrophy; Parkinson Disease; Pergolide | 2002 |
Effect of pergolide mesylate, an ergoline, in animal models of Parkinson's disease: implications for therapy.
Topics: Animals; Antiparkinson Agents; Ergolines; Guinea Pigs; Parkinson Disease; Pergolide; Rats | 1979 |
Sensitive, specific radioimmunoassay for quantifying pergolide in plasma.
Topics: Animals; Antibodies, Monoclonal; Humans; Kinetics; Macaca mulatta; Microchemistry; Parkinson Disease; Pergolide; Radioimmunoassay | 1992 |
Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide)
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Lactose; Levodopa; Male; Methylcellulose; Middle Aged; Oxazines; Parkinson Disease; Pergolide | 1992 |
Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients.
Topics: Adult; Brain Tissue Transplantation; Bromocriptine; Caudate Nucleus; Down-Regulation; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Neurotransmitter; Spiperone | 1991 |
Treating the progressive stages of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline | 1991 |
Pergolide (Celance)--a third dopamine agonist.
Topics: Humans; Parkinson Disease; Pergolide | 1991 |
Comparison of combination pergolide and levodopa to levodopa alone after 63 months of treatment.
Topics: Aged; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies; Statistics as Topic | 1991 |
Early dopamine agonist therapy in Parkinson's disease.
Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine | 1989 |
Agonist substitution in advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Drug Evaluation; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1989 |
MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine Agents; Female; Humans; Hypromellose Derivatives; Lactose; Levodopa; Lisuride; Methylcellulose; Middle Aged; Nausea; Oxazines; Parkinson Disease; Pergolide; Psychomotor Performance; Receptors, Dopamine | 1988 |
Comparative efficacy of two dopamine agonists, pergolide and lergotrile, in Parkinson disease.
Topics: Adult; Aged; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies | 1988 |
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
[Clinical study of pergolide in Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease; Pergolide | 1985 |
Treatment of Parkinson's disease.
Topics: Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide | 1988 |
Hallucinations and confusion after pergolide withdrawal.
Topics: Aged; Cognition Disorders; Confusion; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Substance Withdrawal Syndrome | 1988 |
International symposium on early dopamine agonist therapy of Parkinson's disease.
Topics: Animals; Bromocriptine; Carbidopa; Dopamine; Humans; Levodopa; Parkinson Disease; Pergolide; Time Factors | 1988 |
Mesulergine and pergolide in previously untreated Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Domperidone; Ergolines; Female; Humans; Male; Parkinson Disease; Pergolide | 1987 |
Long-term efficacy of pergolide in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1986 |
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis | 1986 |
Pergolide mesylate: four years experience in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1987 |
Efficacy of pergolide and mesulergine.
Topics: Aged; Antiparkinson Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1986 |
[Dopaminergic agonists in Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil | 1986 |
Long-term study of pergolide in Parkinson's disease.
Topics: Adult; Aged; Disability Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1985 |
Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study.
Topics: Aged; Carbidopa; Drug Combinations; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Receptors, Dopamine; Sleep Wake Disorders; Sleep, REM | 1985 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |
The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease.
Topics: Adult; Aged; Alanine Transaminase; Antiparkinson Agents; Aspartate Aminotransferases; Cognition Disorders; Dopamine; Drug Evaluation; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Nausea; Neurologic Examination; Parkinson Disease; Pergolide; Vasculitis | 1985 |
[Effect of pergolide on the kinetics of the dopamine receptors in the corpus striatum of the rat].
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Ergolines; In Vitro Techniques; Male; Parkinson Disease; Pergolide; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1985 |